ranitidine
Mixed decisions from scheduling committee
Ranitidine set to remain an S3 medicine, while TGA decides to downschedule migraine and acne treatments The Therapeutic Goods Administration (TGA) scheduling delegate has confirmed that the reflux treatment ranitidine …
Proposal to increase pack sizes for general sale of ranitidine rejected
Pharmacist intervention for the drug is “critical”, says delegate, while further interim decisions were made to downschedule rizatriptan, modified release melatonin and topical adapalene An interim decision has been made …
Product shortages
TGA releases list of Ranitidine products impacted by recall Ranitidine tablets and oral liquids are now in short supply as a number of commonly-used brands have been recalled from pharmacies, …
Recall underway
Recall notice issued for several Zantac brands following contamination fear The TGA is advising consumers and health professionals that several ranitidine-containing products have been removed from the Australian market due …